Clinical Trial

Pediatric Delirium

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-12-09; most recent amendment 2026-07-13.
Status change: Suspended → Enrolling by Invitation 2025-07-22
Status change: Recruiting → Suspended 2025-04-18
Status change: Not Yet Recruiting → Recruiting 2021-05-07
Trial Details
NCT Number NCT04669457
Lead Sponsor University of Massachusetts, Worcester
Conditions Pediatric Delirium
Enrollment 60 participants
Start Date 2021-04-27
Primary Completion 2027-04-05 (estimated)
Study Completion 2027-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-15